Scheie syndrome
Scheie syndrome (pronounced SHAY syndrome) is a rare genetic disorder, and the mildest form of Mucopolysaccharidosis type I (MPS I). It is named after Harold Glendon Scheie, an American ophthalmologist who first described the condition in 1962.
Etymology
The syndrome is named after Harold Glendon Scheie, who first described the condition. The term "syndrome" is derived from the Greek word "σύνδρομον" (sýndromon), meaning "concurrence of symptoms" or "concurrence of running together".
Definition
Scheie syndrome is a metabolic disorder characterized by a deficiency of the enzyme alpha-L-iduronidase, which is involved in the breakdown of glycosaminoglycans (GAGs) in the body. This deficiency leads to the accumulation of GAGs in various tissues and organs, causing a range of symptoms.
Symptoms
Symptoms of Scheie syndrome can vary widely among affected individuals. They may include corneal clouding, glaucoma, carpal tunnel syndrome, joint stiffness, and heart disease. Unlike more severe forms of MPS I, individuals with Scheie syndrome typically have normal intelligence and a near-normal life expectancy.
Diagnosis
Diagnosis of Scheie syndrome is based on clinical examination, identification of characteristic symptoms, detailed patient history, and specialized tests such as enzyme assay and genetic testing.
Treatment
There is currently no cure for Scheie syndrome. Treatment is symptomatic and supportive, and may include enzyme replacement therapy (ERT), physical therapy, and surgery to manage specific symptoms.
See also
External links
- Medical encyclopedia article on Scheie syndrome
- Wikipedia's article - Scheie syndrome
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski